Pulse Biosciences
PLSE
31 hedge funds and large institutions have $5.28M invested in Pulse Biosciences in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 12 reducing their positions, and 15 closing their positions.
20% more capital invested
Capital invested by funds: $4.38M → $5.28M (+$892K)
1.68% less ownership
Funds ownership: 8.26% → 6.58% (-1.7%)
30% less funds holding
Funds holding: 44 → 31 (-13)
50% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 12
80% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$35.7K |
| 2 |
GAM
Griffin Asset Management
New York
|
+$28.2K |
| 3 |
Citigroup
New York
|
+$7.11K |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$4.45K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$3.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$457K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$103K |
| 3 |
Millennium Management
New York
|
-$100K |
| 4 |
JMPWA
JP Morgan Private Wealth Advisors
San Francisco,
California
|
-$73K |
| 5 |
WIM
Westside Investment Management
Santa Monica,
California
|
-$54.4K |
PLSE Hedge Fund Activity: Q3 2022 in Review
31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Pulse Biosciences (PLSE) for Q3 2022, worth a combined $5.28M — up 20% from $4.38M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of PLSE and 3 opened new positions — a net loss of 12 holders — while 12 trimmed existing stakes and 6 added.
The largest buyer was Osaic Holdings, adding an estimated $35.7K. The largest seller was Morgan Stanley, cutting an estimated $457K.
- 31 institutional investors held Pulse Biosciences (PLSE) as of Q3 2022, down from 44 in Q2 2022.
- Funds reported $5.28M of Pulse Biosciences stock for Q3 2022, up 20% quarter-over-quarter.
- 3 funds opened new Pulse Biosciences positions in Q3 2022 and 15 closed out, a net change of -12 holders.
- The largest Pulse Biosciences buyer in Q3 2022 was Osaic Holdings, an estimated $35.7K added.
- The largest Pulse Biosciences seller in Q3 2022 was Morgan Stanley, an estimated $457K sold.
Based on aggregated 13F filings for Q3 2022.